搜索结果: '【┃咨询Q2⒏7⒏01705】】华宇登录3'
清除全部
- N2133 7-Ethyl-10-hydroxycamptothecinTarget: TopoisomerasesSummary: TOPO I抑制剂
- B5864 Fruquintinib(HMPL-013)中文名: 呋喹替尼Target: VEGFRSummary: VEGFR1\2和3抑制剂
- B5835 AZD2932Target: FLT3|VEGFR|PDGFR|c-KitSummary: VEGFR-2\PDGFRβ\Flt-3和c-Kit的抑制剂
- A2949 Linifanib (ABT-869)Target: VEGFR|PDGFRSummary: VEGFR/PDGFR抑制剂
- A8550 Telatinib (BAY 57-9352)中文名: 替拉替尼Target: VEGFR|PDGFR|c-KitSummary: VEGFR-2/-3、PDGFR-β和c-Kit抑制剂
- A5057 MGCD-265Target: VEGFR|c-METSummary: Met/Flt/Flk/Ron/Tie-2抑制剂
- A8236 Regorafenib4 Citation中文名: 瑞戈非尼Target: Raf|VEGFR|PDGFR|c-Kit|RETSummary: VEGFR/PDGFR/FGFR/mutant Kit/RET/Raf-1抑制剂
- A8255 Sunitinib malate2 Citation中文名: 苹果酸舒尼替尼Target: VEGFRSummary: VEGFR/PDGFRβ/ KIT/ FLT3/RET/CSF-1R抑制剂
- A4536 Fostriecin sodium saltTarget: PP1|PP2A|Topoisomerases|PP4Summary: 抗肿瘤抗生素
- B4745 (S)-10-Hydroxycamptothecin中文名: 羟喜树碱Target: TopoisomerasesSummary: 拓扑异构酶I抑制剂